US/UK/Canada

Share

About Us

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

Quotes

“The Free Online Memory Test allows individuals to take a scientifically-based assessment that can pinpoint potential problems with their cognitive functioning.
Mark Underwood, President Quincy Bioscience
Pick a time period -
Tags ( Active)

Quincy Bioscience Celebrates Research on World Alzheimer’s Day

Madison, Wis -- (September 14, 2012) In honor of World Alzheimer’s Day, Quincy Bioscience would like to celebrate by offering a free memory tracking tool . Quincy Bioscience, based in Madison, WI, is a biotechnology company committed to improving cognitive health in the aging population.  With 78 million baby boomers in the United States, and crippling statistics on the rate of Alzheimer’s in individuals over 65, concerns for brain health are becoming a national topic. Memory concerns from family issues are leading people to be more proactive about

Quincy Bioscience Congratulates Glen Campbell on Lifetime Achievement

Madison, Wisconsin (February 14, 2012) – Quincy Bioscience  is proud to join the Recording Academy in congratulating Glen Campbell, American country music singer, as he is awarded the 2012 Grammy Lifetime Achievement award. Glen Campbell has spent more than 50 years creating music that revolutionized the entertainment industry. Campbell courageously announced in June of 2011 that he has been diagnosed with Alzheimer’s disease and a result is performing his “Goodbye Tour” across the country. Alzheimer’s disease is a progressive and degenerative brain

Jellyfish Protein a Hot Topic at International Conference on Alzheimer’s Disease

Paris, France -- (July 20, 2011) Quincy Bioscience , a research-based biotechnology company, presented data today which demonstrates an apoaequorin-containing supplement is able to significantly improve cognitive function for adults with memory concerns. The trial findings were shared today in the “Hot Topics” category at the annual Alzheimer’s Association International Conference (AAIC) in Paris. Quincy Bioscience President Mark Underwood presented the results of the Madison Memory Study to the world’s leading Alzheimer’s disease researchers interested in

Dogs Demonstrate Jellyfish Protein as a Potential Therapeutic for Memory Disorders at International Conference on Alzheimer’s Disease

Dogs Demonstrate Jellyfish Protein as a Potential Therapeutic for Memory Disorders at International Conference on Alzheimer’s Disease Paris, France -- (July 20, 2011) Quincy Animal Health, a leader in canine cognitive health, is pleased to announce that Quincy Animal Health President Mark Underwood presented data today which demonstrates an apoaequorin-containing chewable supplement is able to significantly improve cognitive function in senior dogs at the annual Alzheimer’s Association International Conference (AAIC) in Paris. Mr. Underwood presented data from two separate trials

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media